Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metastasis awakening: targeting dormant cancer.

Literature DB >> 23467238

Metastasis awakening: targeting dormant cancer.

Julio A Aguirre-Ghiso¹, Paloma Bragado, Maria Soledad Sosa.

Abstract

Entities: CellLine Chemical Disease Gene Species

Mesh：

Year: 2013 PMID： 23467238 PMCID： PMC3651698 DOI： 10.1038/nm.3120

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

× No keyword cloud information.

14 in total

1. Perspective: The right trials.

Authors: Patricia S Steeg
Journal: Nature Date: 2012-05-30 Impact factor: 49.962

2. A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease.

Authors: Vanessa C Thompson; Tanya K Day; Tina Bianco-Miotto; Luke A Selth; Guangzhou Han; Mervyn Thomas; Grant Buchanan; Howard I Scher; Colleen C Nelson; Norman M Greenberg; Lisa M Butler; Wayne D Tilley
Journal: Int J Cancer Date: 2012-01-24 Impact factor: 7.396

Review 3. ERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease.

Authors: Maria Soledad Sosa; Alvaro Avivar-Valderas; Paloma Bragado; Huei-Chi Wen; Julio A Aguirre-Ghiso
Journal: Clin Cancer Res Date: 2011-06-14 Impact factor: 12.531

Review 4. Framework models of tumor dormancy from patient-derived observations.

Authors: Christoph A Klein
Journal: Curr Opin Genet Dev Date: 2010-12-08 Impact factor: 5.578

5. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.

Authors: Nikolas H Stoecklein; Stefan B Hosch; Martin Bezler; Franziska Stern; Claudia H Hartmann; Christian Vay; Annika Siegmund; Peter Scheunemann; Paulus Schurr; Wolfram T Knoefel; Pablo E Verde; Uta Reichelt; Andreas Erbersdobler; Roger Grau; Axel Ullrich; Jakob R Izbicki; Christoph A Klein
Journal: Cancer Cell Date: 2008-05 Impact factor: 31.743

6. The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.

Authors: Hua Gao; Goutam Chakraborty; Ai Ping Lee-Lim; Qianxing Mo; Markus Decker; Alin Vonica; Ronglai Shen; Edi Brogi; Ali H Brivanlou; Filippo G Giancotti
Journal: Cell Date: 2012-08-17 Impact factor: 41.582

Review 7. Models, mechanisms and clinical evidence for cancer dormancy.

Authors: Julio A Aguirre-Ghiso
Journal: Nat Rev Cancer Date: 2007-11 Impact factor: 60.716

8. Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.

Authors: Jean-Claude A Marshall; Joshua W Collins; Joji Nakayama; Christine E Horak; David J Liewehr; Seth M Steinberg; Mary Albaugh; Fernando Vidal-Vanaclocha; Diane Palmieri; Maryse Barbier; Maximilien Murone; Patricia S Steeg
Journal: J Natl Cancer Inst Date: 2012-08-21 Impact factor: 13.506

9. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone.

Authors: Aya Kobayashi; Hiroshi Okuda; Fei Xing; Puspa R Pandey; Misako Watabe; Shigeru Hirota; Sudha K Pai; Wen Liu; Koji Fukuda; Christopher Chambers; Andrew Wilber; Kounosuke Watabe
Journal: J Exp Med Date: 2011-11-28 Impact factor: 14.307

10. Latent bone metastasis in breast cancer tied to Src-dependent survival signals.

Authors: Xiang H-F Zhang; Qiongqing Wang; William Gerald; Clifford A Hudis; Larry Norton; Marcel Smid; John A Foekens; Joan Massagué
Journal: Cancer Cell Date: 2009-07-07 Impact factor: 31.743

45 in total

1. Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers.

Authors: Vasudha Murlidhar; Rishindra M Reddy; Shamileh Fouladdel; Lili Zhao; Martin K Ishikawa; Svetlana Grabauskiene; Zhuo Zhang; Jules Lin; Andrew C Chang; Philip Carrott; William R Lynch; Mark B Orringer; Chandan Kumar-Sinha; Nallasivam Palanisamy; David G Beer; Max S Wicha; Nithya Ramnath; Ebrahim Azizi; Sunitha Nagrath
Journal: Cancer Res Date: 2017-07-17 Impact factor: 12.701

Metastasis awakening: targeting dormant cancer.

1. Perspective: The right trials.

2. A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease.

Review 3. ERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease.

Review 4. Framework models of tumor dormancy from patient-derived observations.

5. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.

6. The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.

Review 7. Models, mechanisms and clinical evidence for cancer dormancy.

8. Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.

9. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone.

10. Latent bone metastasis in breast cancer tied to Src-dependent survival signals.

1. Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers.

2. Tunable hydrogels for controlling phenotypic cancer cell states to model breast cancer dormancy and reactivation.

3. Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells.

4. Roadblocks to translational advances on metastasis research.

Review 5. The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow.

Review 6. Mechanisms of disseminated cancer cell dormancy: an awakening field.

Review 7. Cancer metastasis - tricks of the trade.

8. Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment.

9. ctcRbase: the gene expression database of circulating tumor cells and microemboli.

10. Cancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs).